This article was originally published in The Gray Sheet
Ventricular assist device procedure code 37.66 will remain assigned to diagnosis related groups 104 or 105 (Cardiac Valve and Other Major Cardiothoracic Procedures) rather than being assigned to DRG 103 (Heart Transplant), according to a proposed rule on the hospital inpatient payment system issued in the May 5 Federal Register. The Health Care Financing Administration denied a request to move all VADs to DRG 103 "since heart assist devices are used across DRGs." Of the 47 procedures performed on Medicare beneficiaries in 1999, only 13 involved heart transplants and were assigned to DRG 103
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.